MK-7602
- Generic Name
- MK-7602
A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)
- First Posted Date
- 2025-01-28
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 34
- Registration Number
- NCT06797674
- Locations
- 🇺🇸
Fortrea Clinical Research Unit Inc ( Site 0001), Daytona Beach, Florida, United States
A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Other: Plasmodium falciparum
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 16
- Registration Number
- NCT06294912
- Locations
- 🇦🇺
USC Clinical Trials Brisbane (South Bank) ( Site 0001), South Brisbane, South Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath